Recursion Pharmaceuticals CEO sells 301,800 in stock
| DTEYX Fund | USD 81.51 0.85 1.05% |
Slightly above 51% of Dreyfus Technology's investors are presently thinking to get in. The analysis of overall sentiment of trading Dreyfus Technology Growth mutual fund suggests that some investors are interested at this time. Dreyfus Technology's investing sentiment can be driven by a variety of factors including economic data, Dreyfus Technology's earnings reports, geopolitical events, and overall market trends.
Dreyfus |
Recursion Pharmaceuticals CEO sells 301,800 in stock
Read at investing.com
 |
Dreyfus Technology Fundamental Analysis
We analyze Dreyfus Technology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dreyfus Technology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dreyfus Technology based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Position Weight
Cash Position Weight Comparative Analysis
Dreyfus Technology is currently under evaluation in cash position weight among similar funds. Percentage of fund asset invested in cash equivalents or risk-free instruments. About 40% of all global funds carry cash on their balance sheet.
Dreyfus Technology Growth Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Dreyfus Technology mutual fund to make a market-neutral strategy. Peer analysis of Dreyfus Technology could also be used in its relative valuation, which is a method of valuing Dreyfus Technology by comparing valuation metrics with similar companies.
Peers
Dreyfus Technology Related Equities
| RYCCX | Nasdaq 100 | 2.19 | ||||
| MFTFX | Arrow Managed | 1.61 | ||||
| BOGSX | Black Oak | 1.10 | ||||
| TMSRX | T Rowe | 0.21 | ||||
| RALCX | Growth Strategy | 0.17 | ||||
| TEOJX | Transamerica Emerging | 0.00 | ||||
| PACEX | T Rowe | 0.00 |
Other Information on Investing in Dreyfus Mutual Fund
Dreyfus Technology financial ratios help investors to determine whether Dreyfus Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Dreyfus with respect to the benefits of owning Dreyfus Technology security.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |